{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:52:49Z","timestamp":1740135169539,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatitis C virus (HCV) infection is a major global concern, with Indigenous Peoples bearing the highest burden. Previous studies exploring HCV prevalence within Indigenous populations have predominantly used a pan-Indigenous approach, consequently resulting in limited availability of M\u00e9tis-specific HCV data. The M\u00e9tis are one of the three recognized groups of Indigenous Peoples in Canada with a distinct history and language. The M\u00e9tis Nation of Ontario (MNO) is the only recognized M\u00e9tis government in Ontario. This study aims to examine the prevalence of self-reported HCV testing and positive results among citizens of the MNO, as well as to explore the association between sociodemographic variables and HCV testing and positive results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A population-based online survey was implemented by the MNO using their citizenship registry between May 6 and June 13, 2022. The survey included questions about hepatitis C testing and results, socio-demographics, and other health related outcomes. Census sampling was used, and 3,206 MNO citizens responded to the hepatitis C-related questions. Descriptive statistics and bivariate analysis were used to analyze the survey data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the respondents, 827 (25.8%, CI: 24.3\u201327.3) reported having undergone HCV testing and 58 indicated testing positive, resulting in a prevalence of 1.8% (CI: 1.3\u20132.3). Respondents with a strong sense of community belonging, higher education levels, and lower household income were more likely to report having undergone HCV testing. Among those who had undergone testing, older age groups, individuals with lower education levels, and retired individuals were more likely to test positive for HCV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study is the first M\u00e9tis-led and M\u00e9tis-specific study to report on HCV prevalence among M\u00e9tis citizens. This research contributes to the knowledge base for M\u00e9tis health and will support the MNO\u2019s health promotion program and resources for HCV. Future research will examine the actual HCV incidence and prevalence among MNO citizens.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09171-w","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T10:02:27Z","timestamp":1709719347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C (HCV) prevalence in citizens of the M\u00e9tis Nation of Ontario"],"prefix":"10.1186","volume":"24","author":[{"given":"Noel","family":"Tsui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel B.","family":"Tjong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail J.","family":"Simms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Cripps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"9171_CR1","unstructured":"Public Health Agency of Canada. People Living with Hepatitis C, Canada., 2019 [Internet]. 2019. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/infographic-people-living-with-hepatitis-c.html."},{"key":"9171_CR2","unstructured":"Public Health Ontario, Hepatitis C. in Ontario, 2018: Surveillance summary one year after a case definition update [Internet]. 2020. 35 p. Available from: https:\/\/www.publichealthontario.ca\/en\/diseases-and-conditions\/infectious-diseases\/blood-borne-infections\/hepatitis-c."},{"issue":"6","key":"9171_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1155\/2013\/380963","volume":"27","author":"J Uhanova","year":"2013","unstructured":"Uhanova J, Tate RB, Tataryn DJ, Minuk GY. The epidemiology of hepatitis C in a Canadian indigenous population. Can J Gastroenterol. 2013;27(6):336\u201340.","journal-title":"Can J Gastroenterol"},{"key":"9171_CR4","doi-asserted-by":"publisher","unstructured":"Pearce ME, Jongbloed K, Demerais L, MacDonald H, Christian WM, Sharma R et al. Another thing to live for: Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities. International Journal of Drug Policy [Internet]. 2019;74:52\u201361. https:\/\/doi.org\/10.1016\/j.drugpo.2019.08.003.","DOI":"10.1016\/j.drugpo.2019.08.003"},{"issue":"3","key":"9171_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3138\/canlivj.2018-0009","volume":"1","author":"ST Fayed","year":"2018","unstructured":"Fayed ST, King A, King M, Macklin C, Demeria J, Rabbitskin N, et al. In the eyes of indigenous people in Canada: exposing the underlying colonial etiology of hepatitis c and the imperative for trauma-informed care. Can Liver J. 2018;1(3):116\u201329.","journal-title":"Can Liver J"},{"issue":"3","key":"9171_CR6","doi-asserted-by":"publisher","first-page":"E897","DOI":"10.9778\/cmajo.20200247","volume":"9","author":"A Mendlowitz","year":"2021","unstructured":"Mendlowitz A, Bremner KE, Walker JD, Wong WWL, Feld JJ, Sander B, et al. Health care costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study. CMAJ Open. 2021;9(3):E897\u2013906.","journal-title":"CMAJ Open"},{"key":"9171_CR7","unstructured":"Gordon J, Bocking N, Pouteau K, Farrell T, Ryan G, Kelly L. First Nations hepatitis C virus infections. Canadian Family Physician [Internet]. 2017;63:e488\u201394. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5685465\/pdf\/063e488.pdf."},{"issue":"1","key":"9171_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/epirev\/mxz015","volume":"41","author":"V Bruce","year":"2019","unstructured":"Bruce V, Eldredge J, Leyva Y, Mera J, English K, Page K. Hepatitis C virus infection in indigenous populations in the United States and Canada. Epidemiol Rev. 2019;41(1):158\u201367.","journal-title":"Epidemiol Rev"},{"key":"9171_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-7-16","volume":"7","author":"SY Shaw","year":"2010","unstructured":"Shaw SY, Deering KN, Jolly AM, Wylie JL. Increased risk for hepatitis C associated with solvent use among Canadian Aboriginal injection drug users. Harm Reduct J. 2010;7:1\u20138.","journal-title":"Harm Reduct J"},{"key":"9171_CR10","unstructured":"Government of Canada. M\u00e9tis [Internet]. 2021 [cited 2023 Jul 6]. Available from: https:\/\/www.rcaanc-cirnac.gc.ca\/eng\/1100100014427\/1535467913043."},{"key":"9171_CR11","unstructured":"M\u00e9tis. Nation of Ontario| About the MNO [Internet]. [cited 2023 Jul 6]. Available from: https:\/\/www.metisnation.org\/about-the-mno\/."},{"issue":"1","key":"9171_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF03404064","volume":"103","author":"MB Kumar","year":"2012","unstructured":"Kumar MB, Wesche S, McGuire C. Trends in M\u00e9tis-related health research (1980\u20132009): identification of research gaps. Can J Public Health. 2012;103(1):23\u20138.","journal-title":"Can J Public Health"},{"issue":"1","key":"9171_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12546-016-9161-4","volume":"33","author":"C Andersen","year":"2016","unstructured":"Andersen C. The colonialism of Canada\u2019s M\u00e9tis health population dynamics: caught between bad data and no data at all. J Popul Res. 2016;33(1):67\u201382.","journal-title":"J Popul Res"},{"key":"9171_CR14","first-page":"5","volume-title":"Land, family and identity: contextualizing Metis health and well-being","author":"B Macdougall","year":"2017","unstructured":"Macdougall B. Land, family and identity: contextualizing Metis health and well-being. Prince George: National Collaborating Centre for Aboriginal Health; 2017. pp. 5\u201323."},{"key":"9171_CR15","unstructured":"National Aboriginal Health Organization. Principles of Ethical M\u00e9tis Research. 2010; Available from: www.naho.ca."},{"issue":"1","key":"9171_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0191184","volume":"13","author":"S Bolotin","year":"2018","unstructured":"Bolotin S, Feld JJ, Garber G, Wong WWL, Guerra FM, Mazzulli T. Population-based estimate of hepatitis C virus prevalence in Ontario, Canada. PLoS ONE. 2018;13(1):1\u201310.","journal-title":"PLoS ONE"},{"issue":"3","key":"9171_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3138\/canlivj.2019-0023","volume":"3","author":"F Zietara","year":"2020","unstructured":"Zietara F, Crotty P, Houghton M, Tyrrell L, Coffin CS, Macphail G. Sociodemographic risk factors for hepatitis c virus infection in a prospective cohort study of 257 persons in Canada who inject drugs. Can Liver J. 2020;3(3):277\u201385.","journal-title":"Can Liver J"},{"issue":"12","key":"9171_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.14745\/ccdr.v47i12a01","volume":"47","author":"L Louren\u00e7o","year":"2021","unstructured":"Louren\u00e7o L, Kelly M, Tarasuk J, Stairs K, Bryson M, Popovic N, et al. The hepatitis C epidemic in Canada: an overview of recent trends in surveillance, injection drug use, harm reduction and treatment. Can Commun Dis Rep. 2021;47(12):505\u201314.","journal-title":"Can Commun Dis Rep"},{"issue":"3","key":"9171_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14745\/ccdr.v42i03a02","volume":"42","author":"S Ha","year":"2016","unstructured":"Ha S, Totten S, Pogany L, Wu J, Gale-Rowe M. Hepatitis C in Canada and the importance of risk-based screening. Can Commun Dis Rep. 2016;42(3):57\u201362.","journal-title":"Can Commun Dis Rep"},{"key":"9171_CR20","doi-asserted-by":"crossref","unstructured":"Graham S, Harrod ME, Iversen J, Hocking JS. Prevalence of hepatitis C among Australian aboriginal and torres strait islander people: a systematic review and meta-analysis. Hepat Mon. 2016;16(7).","DOI":"10.5812\/hepatmon.38640"},{"issue":"3","key":"9171_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10096-007-0267-7","volume":"26","author":"HX Wu","year":"2006","unstructured":"Wu HX, Wu J, Wong T, Andonov A, Li Q, Dinner K, et al. Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-aboriginal canadians in six regions, 1999\u20132004. Eur J Clin Microbiol Infect Dis. 2006;26(3):167\u201374.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9171_CR22","doi-asserted-by":"crossref","unstructured":"Kukutai T, Taylor J. Data sovereignty for indigenous peoples: current practice and future needs. Indigenous Data Sovereignty: toward an agenda. ANU; 2016. pp. 1\u201323.","DOI":"10.22459\/CAEPR38.11.2016.01"},{"key":"9171_CR23","unstructured":"BC Centre for Disease Control. STIGMA & HEPATITIS C: A FACT SHEET FOR HEALTH CARE PROVIDERS Stigma: A Side Effect of Hepatitis C.:1\u20134."},{"issue":"40","key":"9171_CR24","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.3748\/wjg.v19.i40.6703","volume":"19","author":"RT Marinho","year":"2013","unstructured":"Marinho RT, Barreira DP, Hepatitis C. Stigma and cure. World J Gastroenterol. 2013;19(40):6703\u20139.","journal-title":"World J Gastroenterol"},{"key":"9171_CR25","doi-asserted-by":"publisher","unstructured":"Boucher LM, Bayoumi AM, Mark AE, Cooper C, Martin A, Marshall Z et al. Hepatitis C Testing, Status and Treatment among Marginalized People Who Use Drugs in an Inner City Setting: An Observational Cohort Study. Subst Use Misuse [Internet]. 2019;54(1):18\u201330. https:\/\/doi.org\/10.1080\/10826084.2018.1485699.","DOI":"10.1080\/10826084.2018.1485699"},{"issue":"2","key":"9171_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1465-3362.2012.00502.x","volume":"32","author":"D O\u2019Keefe","year":"2013","unstructured":"O\u2019Keefe D, Aitken C, Higgs P, Dietze P. Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs. Drug Alcohol Rev. 2013;32(2):208\u201310.","journal-title":"Drug Alcohol Rev"},{"issue":"6","key":"9171_CR27","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/003335490612100611","volume":"121","author":"H Hagan","year":"2006","unstructured":"Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006;121(6):710\u20139.","journal-title":"Public Health Rep"},{"key":"9171_CR28","doi-asserted-by":"crossref","unstructured":"Gaudet JC, Keeoukaywin. The visiting way - Fostering an Indigenous research Methodology. Aboriginal Policy Studies [Internet]. 2019;7(2). Available from: https:\/\/journals.library.ualberta.ca\/aps\/index.php\/aps\/article\/view\/29336\/pdf.","DOI":"10.5663\/aps.v7i2.29336"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09171-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09171-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09171-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T10:03:03Z","timestamp":1709719383000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09171-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9171"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09171-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"23 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the University of Toronto Health Sciences Research Ethics Board (#42320). All procedures performed in studies involving human respondents were in accordance with ethical standards of the University of Toronto Health Sciences Research Ethics board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual respondents included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NT\u2019s, SAE\u2019s, AJS\u2019s and SC\u2019s positions were funded by the M\u00e9tis Nation of Ontario. GBT has no conflict of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}